Evidence map›Paper›PMID 41427928›Full record

ArticleEmerging microbes & infections2026

Age-specific prevalence of multiple human papillomavirus infections in a clinical cohort of men: a cross-sectional study in Shenzhen, China.

Huan Liu, Siyu Duan, Wenzhu Chu, Rongqing Yang, Lanlan Wei, Siwei Zhang

Abstract read
In one paragraph

Article in Emerging microbes & infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huan LiuNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen; The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, People's Republic of China.
Siyu DuanNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen; The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, People's Republic of China.
Wenzhu ChuDepartment of Dermatology and Venereology, The Third People's Hospital of Shenzhen; The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, People's Republic of China.
Rongqing YangDepartment of Dermatology and Venereology, The Third People's Hospital of Shenzhen; The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, People's Republic of China.
Lanlan WeiNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen; The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, People's Republic of China.
Siwei ZhangNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen; The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, 9-valent Human Papillomavirus (HPV) vaccines are recommended for males aged 16-26 years in China. Herein, we evaluated the impact of Human Immunodeficiency Virus (HIV) on the prevalence of multiple HPV infections across different age groups of males, including men who have sex with men (MSM), to inform future vaccination strategies. A cohort of 5,033 HPV-infected males were selected from Shenzhen Third People's Hospital between 2018 and 2023. HIV status and basic clinical information were collected. Among this cohort, 766 individuals were identified as MSM. Increasing age was associated with a higher prevalence of multiple HPV infections among HIV

Indexed as

CoinfectionHIV InfectionsPapillomaviridaePapillomavirus InfectionsAdolescentAdultAge FactorsChinaCohort StudiesCross-Sectional StudiesHomosexuality, MaleHumansMaleMiddle AgedPapillomavirus VaccinesPrevalencePapillomavirus VaccinesAgeHIVHPVHPV vaccinesMSM

Identifiers

PMID41427928
PMCPMC12794703

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.